Leveraging enzymes to help scale RNA therapies and other biocatalyst use cases with the CEO of Codexis

blonca9
Dec 21, 2023
1 min read

Stephen Dilly describes how Codexis is trying help RNA companies use enzymes to more efficiently make oligonucleotides, and also as a biocatalyst for other RNA and DNA based products. Afterwards, we take a tour of the company's labs.

Recent Posts

See All

London based Baseimmune shows BiotechTV the new space it moved into in LBIC's Apex Building in Kings Cross where it will use its AI platform to discover and develop new vaccines

London based Laverock Therapeutics shows BiotechTV the new space it moved into in LBIC's Apex Building in Kings Cross where it will be doing its work on programmable gene silencing

The London BioScience Innovation Centre (LBIC) today launched its new Apex Building lab space facility for biotech companies in the heart of the Kings Cross Knowledge Quarter

Leveraging enzymes to help scale RNA therapies and other biocatalyst use cases with the CEO of Codexis

Recent Posts

Join the BiotechTV mailing list

Follow BiotechTV

Sponsors

Sponsor Spotlight